tiprankstipranks
Advertisement
Advertisement
C Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
PremiumPrivate CompaniesC Ray Therapeutics Showcases Radiopharma CRDMO Strength Ahead of ANZSNM2026
5d ago
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma Capabilities Ahead of ANZSNM2026
9d ago
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
Premium
Private Companies
C Ray Therapeutics Highlights Radiopharma CRDMO Capabilities and ANZSNM2026 Presence
9d ago
C Ray Therapeutics Forms Strategic Lu-177 Supply Partnership in China
PremiumPrivate CompaniesC Ray Therapeutics Forms Strategic Lu-177 Supply Partnership in China
1M ago
C Ray Therapeutics, SHINE Technologies Form Lu-177 Supply Partnership in China
Premium
Private Companies
C Ray Therapeutics, SHINE Technologies Form Lu-177 Supply Partnership in China
1M ago
C-Ray Therapeutics Secures Exclusive Lu-177 Supply Rights for Mainland China Through SHINE Deal
Premium
Private Companies
C-Ray Therapeutics Secures Exclusive Lu-177 Supply Rights for Mainland China Through SHINE Deal
1M ago
C Ray Therapeutics Highlights Supply-Chain Push for Actinium-225 and Radiopharma Scale-Up
PremiumPrivate CompaniesC Ray Therapeutics Highlights Supply-Chain Push for Actinium-225 and Radiopharma Scale-Up
1M ago
C Ray Therapeutics Highlights Actinium-225 Supply Chain Strategy Around XDC 2026
Premium
Private Companies
C Ray Therapeutics Highlights Actinium-225 Supply Chain Strategy Around XDC 2026
1M ago
C Ray Therapeutics Highlights Automation Partnerships in Radiopharmaceutical Manufacturing
Premium
Private Companies
C Ray Therapeutics Highlights Automation Partnerships in Radiopharmaceutical Manufacturing
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100